Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
0.549
-0.017 (-3.04%)
At close: Jan 17, 2025, 4:00 PM
0.540
-0.009 (-1.60%)
After-hours: Jan 17, 2025, 7:07 PM EST
Omega Therapeutics Stock Forecast
OMGA's stock price has decreased by -85.14% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Omega Therapeutics stock have an average target of 9.20, with a low estimate of 4.00 and a high estimate of 12. The average target predicts an increase of 1,575.77% from the current stock price of 0.55.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 15, 2024.
Analyst Ratings
The average analyst rating for OMGA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $4 | Buy | Maintains | $9 → $4 | +628.60% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +2,085.79% | Aug 15, 2024 |
| Wedbush | Wedbush | Buy Reiterates $12 | Buy | Reiterates | $12 | +2,085.79% | Aug 7, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +992.90% | Aug 7, 2024 |
| Raymond James | Raymond James | Buy Initiates $12 | Buy | Initiates | $12 | +2,085.79% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
8.71M
from 3.09M
Increased by 181.38%
Revenue Next Year
4.39M
from 8.71M
Decreased by -49.53%
EPS This Year
-1.21
from -1.80
EPS Next Year
-0.66
from -1.21
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9.9M | 6.9M | 6.9M | |||
| Avg | 8.7M | 4.4M | 6.7M | |||
| Low | 7.5M | 2.0M | 6.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 221.0% | -20.2% | 58.1% | |||
| Avg | 181.4% | -49.5% | 53.6% | |||
| Low | 141.0% | -77.5% | 47.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.19 | -0.39 | -0.36 | |||
| Avg | -1.21 | -0.66 | -0.40 | |||
| Low | -1.21 | -1.16 | -0.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.